[go: up one dir, main page]

CN1456363A - Preparing method for heteroossein base materials - Google Patents

Preparing method for heteroossein base materials Download PDF

Info

Publication number
CN1456363A
CN1456363A CN 03117954 CN03117954A CN1456363A CN 1456363 A CN1456363 A CN 1456363A CN 03117954 CN03117954 CN 03117954 CN 03117954 A CN03117954 A CN 03117954A CN 1456363 A CN1456363 A CN 1456363A
Authority
CN
China
Prior art keywords
bone
collagen
xenogenesis
heterogeneous
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 03117954
Other languages
Chinese (zh)
Other versions
CN1214821C (en
Inventor
王远亮
何创龙
杨立华
夏烈文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing University
Original Assignee
Chongqing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing University filed Critical Chongqing University
Priority to CN 03117954 priority Critical patent/CN1214821C/en
Publication of CN1456363A publication Critical patent/CN1456363A/en
Application granted granted Critical
Publication of CN1214821C publication Critical patent/CN1214821C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明涉及骨外科修复材料和骨组织工程细胞外基质材料等生物材料技术领域,具体是一种异种骨胶原基质制备的新方法。本方法选取牛、猪等异种骨,主要经异种骨来源和加工—脱脂处理—部分脱钙—脱非胶原蛋白—蛋白酶消化,最后消毒包装得新型的异种骨胶原基质,该材料保留了原骨的骨矿成分和大部分胶原蛋白,其中的胶原成分经蛋白酶消化后,切除了能够引起免疫原性的端肽,因而免疫原性大大降低。在具有较强力学性能的同时,该材料具有较好的孔隙率和孔道连通,适合用作骨组织工程细胞外基质材料和骨缺损移植材料,为骨移植外科和骨组织工程的发展提供廉价的生物材料。

Figure 03117954

The invention relates to the technical field of biomaterials such as bone surgery repair materials and bone tissue engineering extracellular matrix materials, in particular to a new method for preparing heterogeneous collagen matrix. This method selects heterogeneous bones such as cattle and pigs, and mainly undergoes heterogeneous bone source and processing—degreasing treatment—partial decalcification—decollagen removal—protease digestion, and finally sterilized and packaged to obtain a new type of heterogeneous bone collagen matrix, which retains the original bone The bone mineral component and most of the collagen, among which the collagen component is digested by protease, cut off the telopeptide that can cause immunogenicity, so the immunogenicity is greatly reduced. While having strong mechanical properties, the material has good porosity and pore connectivity, and is suitable for use as extracellular matrix materials for bone tissue engineering and bone defect transplantation materials, providing a cheap alternative for the development of bone transplantation surgery and bone tissue engineering. biomaterials.

Figure 03117954

Description

异种骨胶原基质制备的新方法A New Method for Preparation of Heterogeneous Collagen Matrix

技术领域technical field

本发明涉及骨外科修复材料和骨组织工程细胞外基质材料等生物材料技术领域。更确切地说,本发明涉及到一种采用生物和化学方法处理异种松质骨和皮质骨的方法,以获得可移植的异种骨修复材料和骨组织工程细胞外基质材料。The invention relates to the technical field of biomaterials such as bone surgery repair materials and bone tissue engineering extracellular matrix materials. More precisely, the present invention relates to a method for processing heterogeneous cancellous bone and cortical bone by biological and chemical methods to obtain implantable heterogeneous bone repair materials and bone tissue engineering extracellular matrix materials.

背景技术Background technique

由于创伤、感染、肿瘤以及发育异常等原因使骨丧失了一些骨质,形成较大的间隙,称之为骨缺损。绝大多数骨缺损由于间隙大,成骨细胞难以爬过间隙而不能发生正常的愈合,最终形成骨不连。在美国,每年因为各种原因进行骨移植的手术多达980000例,而在德国,这一数字也高达100000例(Kessler S,Wohlfart U M,Ingnatius A,et al.Solventdehydrated bone transplants to bridge segmental bone defects:histomorphologicaland biomechanical investigations in an animal model.Arch Orthop TraumaSurg,2001,121:472~475)。Due to trauma, infection, tumor and dysplasia, the bone loses some bone quality and forms a large gap, which is called bone defect. Due to the large gaps in most bone defects, it is difficult for osteoblasts to crawl through the gaps and normal healing cannot occur, eventually forming nonunions. In the United States, there are as many as 980,000 cases of bone grafting for various reasons each year, and in Germany, this figure is as high as 100,000 cases (Kessler S, Wohlfart U M, Ingnatius A, et al.Solventdehydrated bone transplants to bridge segmental bone defects: histomorphological and biomechanical investigations in an animal model. Arch Orthop TraumaSurg, 2001, 121: 472-475).

临床证明,自体骨移植一直是治疗骨缺损的最好方法。在病人体内不会发生免疫反应,移植骨中的细胞和生物活性分子能在受体部位继续存活,并发挥相应的功能,促进骨缺损的愈合,但取骨部位容易发病,取骨量有限并且其尺寸和形状常常受到限制。同种异体骨能提供大量不同形状和尺寸的皮质骨或松质骨。但它容易引起免疫反应,在骨缺损边缘与宿主骨的连接速度较慢,并有传染病毒性疾病的危险,而且制样、处理和存贮的成本很高,其应用受到很大限制。人工合成可降解聚合物材料,其组成成分、分子量、力学性能、降解速度等都能预先设计和控制,也容易塑型和构建多孔三维结构,但很多此类材料的降解产物会使体内酸度过高,容易诱发炎症反应。It has been clinically proven that autologous bone grafting has always been the best way to treat bone defects. There will be no immune reaction in the patient's body, and the cells and bioactive molecules in the transplanted bone can continue to survive at the recipient site and perform corresponding functions to promote the healing of the bone defect. Its size and shape are often limited. Bone allografts provide a wide variety of cortical or cancellous bone of various shapes and sizes. However, it is easy to cause immune reaction, the connection speed with the host bone is slow at the edge of the bone defect, and there is a risk of infectious viral diseases, and the cost of sample preparation, processing and storage is very high, and its application is greatly limited. Artificially synthesized degradable polymer materials, its composition, molecular weight, mechanical properties, degradation speed, etc. can be pre-designed and controlled, and it is also easy to shape and build a porous three-dimensional structure, but the degradation products of many such materials will make the body too acidic High, it is easy to induce an inflammatory response.

为了克服这些缺点,人们开始考虑新的骨替代材料,近十多年来发展起来的骨组织工程学,为大范围骨缺损的修复开辟了新的渠道。其中,能够支持细胞粘附、增殖和分化以及释放生物活性因子或种子细胞的基质材料的开发是骨组织工程成功与否的重要条件。天然异种骨具有来源丰富、价格低廉等优点,是骨组织工程细胞外基质材料和骨缺损移植材料的潜在来源之一,但是异种骨含有很多有机成分,其中很多酸溶性蛋白具有免疫原性,植入人体后能够诱发免疫排斥反应,必须彻底脱除。骨基质中的I型胶原,由于有规整的螺旋结构,免疫原性较温和。在胶原分子中95%的氨基酸具有Gly-X-Y的重复序列和三螺旋结构,在两端约5%的氨基酸不具有这种序列而不能形成螺旋结构,这些区域与胶原的免疫原性有关,除掉这些区域可以大大减小免疫原性。因此,如何去除异种骨的抗原性物质并保留其诱导成骨能力是异种骨研究首要解决的问题。In order to overcome these shortcomings, people began to consider new bone substitute materials. The bone tissue engineering developed in the past ten years has opened up a new channel for the repair of large-scale bone defects. Among them, the development of matrix materials that can support cell adhesion, proliferation and differentiation, and release bioactive factors or seed cells is an important condition for the success of bone tissue engineering. Natural xenograft bone has the advantages of rich sources and low price, and is one of the potential sources of extracellular matrix materials for bone tissue engineering and bone defect graft materials. However, xenograft bone contains many organic components, and many acid-soluble proteins are immunogenic. After entering the human body, it can induce immune rejection and must be completely removed. Type I collagen in bone matrix has a milder immunogenicity due to its regular helical structure. 95% of the amino acids in the collagen molecule have the repeated sequence of Gly-X-Y and a triple helix structure, and about 5% of the amino acids at both ends do not have this sequence and cannot form a helical structure. These regions are related to the immunogenicity of collagen, except Removal of these regions can greatly reduce immunogenicity. Therefore, how to remove the antigenic substances of xenograft bone and retain its ability to induce osteogenesis is the primary problem to be solved in xenograft bone research.

国内外关于异种骨的加工方法很多,早在1937年Orell就首次将脱蛋白骨应用于临床,该方法称为Os Purum法,将异种骨除去软组织后用KOH去结缔组织,随后用丙酮脱脂,在盐溶液中脱蛋白。在此后的几十年里,出现了Kiel骨、Oswestry骨和Anorganic骨等多种脱蛋白骨,在这些处理方法中,通常使用NaClO、H2O2和乙二胺等化学试剂来破坏胶原和其它蛋白质。通过脱钙、深低温冷冻、煮沸、射线辐照等方法也能减小或消除其抗原性。目前在骨移植手术中使用的异种骨多采用煅烧骨和经一些物理和化学方法处理的无机骨,为了避免剧烈的免疫排斥反应,通常去除了胶原等重要的有机成分,这种处理方法使移植骨的力学性能很差,因而限制了它的使用(Salama R.Xenogeneic bone grafting in humans.Clin Orthop,1983,174:113~121)。罗卓荆等人采用离心技术、超声波技术和化学处理技术相结合的方法处理牛松质骨,获得了一种无免疫原性并具有一定机械支撑能力的大块形异种骨移植材料(罗卓荆和胡蕴玉,新型块形脱脂去抗原异种骨移植材料及其制备方法,中国专利号ZL97108538.2)。杨志明等人采用物理化学处理方法,将来源于猪骨或异种骨制成生物衍生骨支架,引入高分子材料或活性成分,构建生物衍生组织工程骨(杨志明和秦廷武,生物衍生组织工程骨及其制备方法,中国专利号ZL00132082.3)。这些加工方法能够脱除异种骨的抗原性物质并保留其天然网状结构,但采用H2O2等强氧化性试剂脱除抗原性物质对有机成分的破坏较大,也必然影响其力学强度,特别是松质骨材料,本身的力学强度就很低,文献报道牛松质骨经H2O2处理后,其力学强度明显降低,处理24小时降低43.7%,其压缩极限强度为5.3564MPa,处理96小时降低92.8%,仅为0.6896MPa(罗卓荆,胡蕴玉,候德门,赵婷。牛松质骨力学强度与去抗原处理时限的相关性实验。第四军医大学学报,1996;17(6):434~436)。There are many processing methods of heterogeneous bone at home and abroad. As early as 1937, Orell first applied deproteinized bone to clinical practice. This method is called Os Purum method. After removing soft tissue from heterogeneous bone, KOH is used to remove connective tissue, and then degreased with acetone. Deproteinize in saline solution. In the following decades, various deproteinized bones such as Kiel bone , Oswestry bone , and Anorganic bone appeared. other proteins. Its antigenicity can also be reduced or eliminated by methods such as decalcification, cryogenic freezing, boiling, and radiation irradiation. At present, most of the heterogeneous bones used in bone transplantation are calcined bone and inorganic bone treated by some physical and chemical methods. In order to avoid severe immune rejection, important organic components such as collagen are usually removed. The mechanical properties of bone are poor, thus limiting its use (Salama R. Xenogeneic bone grafting in humans. Clin Orthop, 1983, 174: 113-121). Luo Zhuojing et al. used a combination of centrifugal technology, ultrasonic technology and chemical treatment technology to process bovine cancellous bone, and obtained a large block-shaped xenograft bone graft material with no immunogenicity and certain mechanical support ability (Luo Zhuojing Jing and Hu Yunyu, Novel bulk defatted and antigen-removed xenograft material and its preparation method, Chinese Patent No. ZL97108538.2). Yang Zhiming and others used physical and chemical treatment methods to make bio-derived bone scaffolds from pig bones or heterogeneous bones, and introduced polymer materials or active ingredients to construct bio-derived tissue-engineered bones (Yang Zhiming and Qin Tingwu, Bio-derived tissue-engineered bone and its Preparation method, Chinese Patent No. ZL00132082.3). These processing methods can remove the antigenic substances of xenograft bone and retain its natural network structure, but the use of strong oxidizing reagents such as H 2 O 2 to remove the antigenic substances will greatly damage the organic components and will inevitably affect its mechanical strength , especially the cancellous bone material itself has very low mechanical strength. It has been reported in the literature that the mechanical strength of bovine cancellous bone is significantly reduced after being treated with H 2 O 2 , and its compressive ultimate strength is 5.3564MPa. , reduced by 92.8% in 96 hours, only 0.6896MPa (Luo Zhuojing, Hu Yunyu, Hou Demen, Zhao Ting. Correlation experiment between the mechanical strength of bovine cancellous bone and the time limit of antigen-removing treatment. Journal of Fourth Military Medical University, 1996; 17(6):434-436).

发明内容Contents of the invention

为了克服已有方法的缺点,本发明的目的是研究一种骨胶原基质的制备方法,在去除或减小免疫原性的同时,尽量保持天然骨的骨矿结构和部分有机胶原结构,以增加移植骨的整体力学强度,并保留适当的成骨性能。In order to overcome the shortcoming of existing method, the purpose of the present invention is to study a kind of preparation method of bone collagen matrix, while removing or reducing immunogenicity, keep the bone mineral structure and part organic collagen structure of natural bone as far as possible, to increase The overall mechanical strength of the grafted bone and retain proper osteogenic properties.

本发明主要涉及一种新型异种骨胶原基质的制备方法,其主要的技术特征是:采用一系列生物和化学方法对牛、猪等异种骨进行处理。采用的技术路线如下:The invention mainly relates to a preparation method of a novel heterogeneous collagen matrix, and its main technical feature is that a series of biological and chemical methods are used to process the heterogeneous bones of cattle, pigs and the like. The technical route adopted is as follows:

(1)异种骨材料的来源和加工(1) Source and processing of heterogeneous bone materials

从屠宰场获得新鲜的牛或猪的腿骨,经充分去除软组织、软骨和骨髓后,洗净,置于-20℃的冰箱中冷冻24小时。用低速锯切割使干骺端分离,骨骺端松质骨加工成块状,其长轴与骨小梁的排列方向保持一致,用于制备组织工程细胞外基质材料或骨缺损填充材料;骨干中部加工成圆柱体或条形,用于制备骨缺损移植材料。Fresh bovine or pig leg bones were obtained from slaughterhouses. After fully removing soft tissue, cartilage and bone marrow, they were washed and placed in a -20°C refrigerator for 24 hours. Cutting with a low-speed saw to separate the metaphysis, the cancellous bone of the epiphysis is processed into a block, and its long axis is consistent with the alignment direction of the bone trabecula, which is used to prepare extracellular matrix materials for tissue engineering or bone defect filling materials; the middle part of the backbone Processed into cylinders or strips for the preparation of bone defect graft materials.

(2)脱脂处理(2) Degreasing treatment

加工好的骨块用40~60℃压力水反复冲洗,然后用0.01~5mol/L碱液室温浸泡24h,将骨块置于含脱脂剂的脂肪提取器中于50~60℃下脱脂48~72h,每24h将骨块取出在离心机上以4000转/分钟的速度离心30分钟左右,清除骨块内细胞成分和脂肪等物质,脱脂剂可以采用1∶1~1∶3的甲醇/氯仿、甲酸乙酯、乙酸甲酯、异丙醇或丙酮等有机溶剂。The processed bones were repeatedly washed with 40-60°C pressure water, then soaked in 0.01-5mol/L lye at room temperature for 24 hours, and then placed in a fat extractor containing a degreasing agent and degreased at 50-60°C for 48-48 hours. 72 hours, and every 24 hours, take out the bone block and centrifuge it at a speed of 4000 rpm for about 30 minutes in a centrifuge to remove cellular components, fat and other substances in the bone block. The degreasing agent can be 1:1-1:3 methanol/chloroform, Organic solvents such as ethyl formate, methyl acetate, isopropanol or acetone.

(3)部分脱钙处理(3) Partial decalcification treatment

骨块在0.1~5mol/L酸性溶液中室温下部分脱钙5~10分钟,再用双蒸水反复透析至pH值为6,以去除残留的酸液。Bone fragments were partially decalcified in 0.1-5 mol/L acidic solution at room temperature for 5-10 minutes, and then dialyzed repeatedly with double distilled water until the pH value was 6 to remove residual acid.

(4)脱非胶原蛋白(4) Decollagen

骨块放入含有pH为7.4的脱非胶原蛋白混合液中,该混合液的组成为含氮碱性有机物、Tris缓冲液和盐类,置于4℃的冰箱中脱除非胶原蛋白,时间为24h,可以采用尿素或盐酸胍作为非胶原蛋白脱除剂。The bone pieces were put into the non-collagenous protein mixture containing pH 7.4, the mixture was composed of nitrogen-containing basic organic matter, Tris buffer and salt, and placed in a refrigerator at 4°C to remove the non-collagenous protein, and the time was 24h, urea or guanidine hydrochloride can be used as non-collagen removal agent.

(5)蛋白酶消化(5) Protease digestion

骨块用0.05~0.5%的蛋白酶消化,加入少量巯基酶抑制剂防腐,用缓冲溶液控制溶液的pH为7.8~8.0,骨液比为1∶1~1∶6,在37℃条件下消化48h。再用4mol/L NaCl浸泡12~24h,以脱除溶解的非胶原蛋白和部分胶原蛋白。Digest the bone block with 0.05-0.5% protease, add a small amount of thiolase inhibitor for preservation, use buffer solution to control the pH of the solution to 7.8-8.0, and the bone-to-liquid ratio is 1:1-1:6, and digest at 37°C for 48 hours . Then soak in 4mol/L NaCl for 12-24 hours to remove dissolved non-collagen and part of collagen.

经蛋白酶消化,能进一步脱除骨块中的非胶原蛋白,并使骨块中剩余的胶原脱去端肽,变成无端肽胶原,消除胶原的免疫原性。After protease digestion, the non-collagen protein in the bone block can be further removed, and the remaining collagen in the bone block can be stripped of telopeptide and become antelopeptide collagen, eliminating the immunogenicity of collagen.

(6)消毒和包装(6) Disinfection and packaging

骨块用重蒸水反复冲洗,50℃下真空干燥24h,三层聚乙烯薄膜封装,环氧乙烷消毒2小时,置4℃冰箱中保存备用。The bone fragments were rinsed repeatedly with distilled water, dried in vacuum at 50°C for 24 hours, packaged with three layers of polyethylene film, sterilized with ethylene oxide for 2 hours, and stored in a refrigerator at 4°C for later use.

本发明与现有技术相比具有如下优点:Compared with the prior art, the present invention has the following advantages:

1.采用生物和化学方法制备的松质骨材料,保留了原骨的骨矿成分和大部分胶原蛋白,其中的胶原成分经蛋白酶消化后,切除了能够引起免疫原性的端肽,因而免疫原性大大降低,胶原的存在使材料的力学强度大大改善,同时,该材料具有较好的孔隙率和孔道连通,为成骨细胞等种子细胞的爬行替代提供了良好的条件,适合用作骨组织工程细胞外基质材料。1. The cancellous bone material prepared by biological and chemical methods retains the bone mineral components and most of the collagen of the original bone. After the collagen components are digested by protease, the telopeptides that can cause immunogenicity are excised, so the immune The originality is greatly reduced, and the existence of collagen greatly improves the mechanical strength of the material. At the same time, the material has good porosity and pore connectivity, which provides good conditions for the crawling replacement of osteoblasts and other seed cells, and is suitable for bone Extracellular matrix materials for tissue engineering.

2.采用生物和化学方法制备的皮质骨材料,除了具有低免疫原性和一定的孔隙率之外,还具有优异的力学性能,如按照该方法制备的牛皮质骨材料,其拉伸杨氏模量可达6000Mpa左右,最大应力可达110Mpa左右,与人长骨的力学性能较为接近,在植入体内后,消除了其它植骨材料如金属等由于与人骨力学性能的差异而引起的“应力遮挡”效应。适合用作骨缺损移植材料。2. The cortical bone material prepared by biological and chemical methods, in addition to low immunogenicity and certain porosity, also has excellent mechanical properties, such as the bovine cortical bone material prepared according to this method, its tensile Young's The modulus can reach about 6000Mpa, and the maximum stress can reach about 110Mpa, which is relatively close to the mechanical properties of human long bones. After implantation in the body, it eliminates the "stress" caused by the difference in mechanical properties between other bone graft materials such as metals and human bones. occlusion" effect. Suitable for bone defect grafting material.

3.本发明所制备的材料具有各种不同的外形,可以根据临床上的需要裁切成各种不同的形状,也可以根据需要用抗生素或其它药物进行进一步处理或在其表面引入活性肽、生长因子、可降解聚合物等进行修饰。3. The materials prepared by the present invention have various shapes, which can be cut into various shapes according to clinical needs, and can also be further treated with antibiotics or other drugs or introduced active peptides, Growth factors, degradable polymers, etc. are modified.

本发明的意义在于采用生物和化学方法相结合研制出了新型异种骨胶原基质,为骨移植外科和骨组织工程的发展提供廉价的生物材料,以满足市场的需求。The significance of the invention lies in the combination of biological and chemical methods to develop a new type of heterogeneous collagen matrix, to provide cheap biological materials for the development of bone transplantation surgery and bone tissue engineering, and to meet the needs of the market.

附图说明Description of drawings

图1是本发明所涉及的异种皮质骨胶原基质材料加工过程示意图,1为从屠宰场获得的新鲜猪或牛腿骨,经去除软组织和其它成分后冷冻;2为截取的骨干部分;3为加工好的材料。Fig. 1 is the schematic diagram of the processing process of the heterogeneous cortical bone collagen matrix material involved in the present invention, 1 is the fresh pig or beef leg bone obtained from the slaughterhouse, which is frozen after removing soft tissue and other components; 2 is the backbone part of the interception; 3 is Processed material.

图2是本发明制备的圆柱状和条状材料的外形照片。Figure 2 is a photo of the appearance of cylindrical and strip materials prepared by the present invention.

具体实施方式Detailed ways

实施例1一种牛皮质骨胶原基质材料的制备方法Embodiment 1 A kind of preparation method of bovine cortical bone collagen matrix material

本发明所述的皮质骨材料应取自骨干中部(参见附图1)。加工过程应在冷冻后采用低速锯切割,以免温度较高破坏胶原。加工好的骨块用50℃压力水反复冲洗,然后用0.1mol/LNaOH溶液室温浸泡24h,将骨块置于含有甲酸乙酯的索氏提取器中于60℃下脱脂72h,每24h将骨块取出在离心机上以4000转/min的速度离心30min左右,清除骨块内异物;骨块在0.5mol/L HCl溶液中室温下部分脱钙10min,再用双蒸水反复透析至pH值为6,以去除残留的酸液;骨块放入含有4mol/L HCl胍、50mmol/L Tris-HCl和0.5Mmol/LCaCl2,pH为7.4的溶液中,并置于4℃的冰箱中脱除非胶原蛋白,时间为24h;骨块用0.1%的胰蛋白酶消化,加入少量叠氮化钠溶液防腐,用Na2HPO4和NaH2PO4的缓冲溶液控制溶液的pH为7.8,骨液比为1∶3,在37℃条件下消化48h。再用4mol/LNaCl浸泡12~24h,以脱除溶解的非胶原蛋白和部分胶原蛋白;骨块用重蒸水反复冲洗,50℃下真空干燥24h,三层聚乙烯薄膜封装,环氧乙烷消毒2小时,置4℃冰箱中保存备用。The cortical bone material of the present invention should be taken from the middle of the diaphysis (see accompanying drawing 1). The processing process should be cut with a low-speed saw after freezing to avoid damage to collagen due to high temperature. The processed bone was repeatedly washed with 50°C pressure water, then soaked in 0.1mol/L NaOH solution at room temperature for 24 hours, and the bone was placed in a Soxhlet extractor containing ethyl formate at 60°C for 72 hours, and the bone was degreased every 24 hours. The block was taken out and centrifuged at a speed of 4000 rpm for about 30 min in a centrifuge to remove foreign matter in the bone block; the bone block was partially decalcified in 0.5mol/L HCl solution at room temperature for 10 min, and then dialyzed repeatedly with double distilled water until the pH value was 6. To remove the residual acid solution; put the bone into a solution containing 4mol/L HCl guanidine, 50mmol/L Tris-HCl and 0.5Mmol/L CaCl 2 , with a pH of 7.4, and place it in a refrigerator at 4°C to remove non-toxic acid. Collagen, the time is 24h; the bone block is digested with 0.1% trypsin, a small amount of sodium azide solution is added for preservation, and the buffer solution of Na 2 HPO 4 and NaH 2 PO 4 is used to control the pH of the solution to 7.8, and the bone liquid ratio is 1:3, digested at 37°C for 48h. Soak in 4mol/L NaCl for 12-24 hours to remove the dissolved non-collagen and some collagen; the bone block was washed repeatedly with double-distilled water, dried in vacuum at 50°C for 24 hours, encapsulated with three layers of polyethylene film, ethylene oxide Sterilize for 2 hours and store in a 4°C refrigerator for later use.

实施例2一种牛松质骨胶原基质材料的制备方法Embodiment 2 A kind of preparation method of bovine cancellous bone collagen matrix material

本发明所述的松质骨材料应取材于骨骺端,取其长轴与骨小梁排列方向一致。加工过程应在冷冻后采用低速锯切割成块状,以免温度较高破坏胶原。加工好的骨块用50℃压力水反复冲洗,然后用0.05mol/LNaOH溶液室温浸泡24h,将骨块置于含有1∶1的甲醇/氯仿混合溶剂的索氏提取器中于55~60℃下脱脂72h,每24h将骨块取出在离心机上以4000转/min的速度离心30min左右;骨块在0.1mol/LHCl溶液中室温下部分脱钙10min,再用双蒸水反复透析至pH值为6,以去除残留的酸液;骨块放入含有6mol/L尿素的溶液中,并置于4℃的冰箱中脱除非胶原蛋白,时间为24h;骨块用0.1%的胰蛋白酶消化,加入叠氮化钠溶液防腐,用Na2HPO4和NaH2PO4的缓冲溶液控制溶液的pH为7.8,骨液比为1∶4,在37℃条件下消化36h。再用4M NaCl溶液浸泡12h;骨块用重蒸水反复冲洗,50℃下真空干燥24h,三层聚乙烯薄膜封装,环氧乙烷消毒2小时,置4℃冰箱中保存备用。The cancellous bone material of the present invention should be taken from the epiphysis, and its long axis should be consistent with the arrangement direction of bone trabeculae. The processing process should be cut into blocks with a low-speed saw after freezing to avoid high temperature damage to collagen. The processed bone was repeatedly washed with 50°C pressure water, then soaked in 0.05mol/L NaOH solution at room temperature for 24 hours, and placed in a Soxhlet extractor containing a 1:1 methanol/chloroform mixed solvent at 55-60°C. Degrease for 72 hours, take out the bone pieces every 24 hours, and centrifuge them at a speed of 4000 rpm for about 30 minutes in a centrifuge; partially decalcify the bone pieces in 0.1mol/L HCl solution at room temperature for 10 minutes, and then dialyze them repeatedly with double distilled water to reach the pH value 6, to remove the residual acid; put the bone into a solution containing 6mol/L urea, and place it in a refrigerator at 4°C to remove non-collagen for 24 hours; digest the bone with 0.1% trypsin, Add sodium azide solution for preservation, use a buffer solution of Na 2 HPO 4 and NaH 2 PO 4 to control the pH of the solution to 7.8, and the ratio of bone to fluid to 1:4, and digest at 37°C for 36 hours. Then soak in 4M NaCl solution for 12 hours; the bone fragments were rinsed repeatedly with double distilled water, dried in vacuum at 50°C for 24 hours, packaged with three layers of polyethylene film, sterilized with ethylene oxide for 2 hours, and stored in a refrigerator at 4°C for later use.

本发明制备的圆柱状和条状材料的外形见图2所示的照片。The appearance of the cylindrical and strip materials prepared by the present invention is shown in the photo shown in FIG. 2 .

Claims (4)

1. the new method of xenogenesis bone collagen matrix preparation, it is characterized in that: adopt a series of biological and chemical methods that xenogenesis bones such as cattle, pig are handled, process is as follows:
(1) source of xenogenesis bone material and processing
Choose the thigh bone of fresh cattle or pig, after fully removing soft tissue, cartilage and bone marrow, clean, freezing, the cutting and separating metaphysis is processed into bulk with epiphysis end spongy bone, its major axis and bone trabecular orientation are consistent, and cylinder or bar shaped are processed in key middle part;
(2) ungrease treatment
The bone piece that processes washes repeatedly with 40~60 ℃ of press waters, use 0.01~5mol/L alkali liquor soaking at room temperature 24h then, use degreasing agent in 50~60 ℃ of following defat 48~72h the bone piece, every 24h takes out the bone piece on the centrifuge with 4000 rev/mins speed centrifugal about 30 minutes, removes materials such as bone piece inner cell composition and fat;
(3) partly decalcifying is handled
The room temperature lower part decalcification 5~10 minutes in 0.1~5mol/L acid solution of bone piece, reuse distilled water dialyse repeatedly to pH value be 6, to remove residual acid solution;
(4) take off noncollagen protein
The bone piece puts into that to contain pH value be the mixed liquor that 7.4 noncollagen protein removes agent, this mixed liquor consist of nitrogenous base organic matter, Tris buffer and salt, place 4 ℃ refrigerator to remove noncollagen protein, the time is 24h;
(5) protease digestion
The bone piece is with 0.05~0.5% protease digestion, it is anticorrosion to add a small amount of sulfydryl enzyme inhibitor, pH with buffer solution control solution is 7.8~8.0, the bone liquid ratio is 1: 1~1: 6, under 37 ℃ of conditions, digest 48h, reuse 4mol/LNaCl soaks 12~24h, to remove dissolved noncollagen protein and part collagen protein;
(6) sterilization and packing
2, the new method of xenogenesis bone collagen matrix preparation according to claim 1, it is characterized in that: degreasing agent adopts 1: 1~1: 3 methanol/chloroform, Ethyl formate, methyl acetate, isopropyl alcohol or acetone.
3, the new method of xenogenesis bone collagen matrix preparation according to claim 1 is characterized in that: adopt carbamide or guanidine hydrochloride to remove agent as noncollagen protein.
4. according to the xenogenesis bone collagen matrix of claim 1, the preparation of 2 or 3 described methods, it is characterized in that: the immunogenicity that reduces or eliminate xenogenesis spongy bone such as cattle, pig and cortical bone, collagen protein becomes the ratio of branch to be about 1: 2 with the bone ore deposit, collagen protein has wherein excised the end peptide through Protease Treatment, the material of gained is block, the cylindric or strip of white, the mesh structural porous structure that has kept nature bone, adopt the young's modulus in tension of the collagen stroma material of cattle cortical bone preparation to reach about 6000Mpa, maximum stress reaches about 110Mpa.
CN 03117954 2003-05-27 2003-05-27 A New Method for Preparation of Heterogeneous Collagen Matrix Expired - Fee Related CN1214821C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03117954 CN1214821C (en) 2003-05-27 2003-05-27 A New Method for Preparation of Heterogeneous Collagen Matrix

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03117954 CN1214821C (en) 2003-05-27 2003-05-27 A New Method for Preparation of Heterogeneous Collagen Matrix

Publications (2)

Publication Number Publication Date
CN1456363A true CN1456363A (en) 2003-11-19
CN1214821C CN1214821C (en) 2005-08-17

Family

ID=29411265

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03117954 Expired - Fee Related CN1214821C (en) 2003-05-27 2003-05-27 A New Method for Preparation of Heterogeneous Collagen Matrix

Country Status (1)

Country Link
CN (1) CN1214821C (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007071168A1 (en) * 2005-12-20 2007-06-28 Summit (Gd) Biotech Co., Ltd Biological wound dressing and method of making
WO2007071167A1 (en) * 2005-12-20 2007-06-28 Summit(Gd) Biotech Co., Ltd Biological artificial nerve guide and method of making
WO2007071164A1 (en) * 2005-12-20 2007-06-28 Summit(Gd) Biotech Co., Ltd Biological surgical patch and method of making
CN100358432C (en) * 2003-12-16 2008-01-02 威海市宇王水产有限公司 Production method of fish scale collagen
CN100485002C (en) * 2005-10-18 2009-05-06 中国人民解放军第三军医大学第一附属医院 Bone collagen gel liquid preparation method
CN101616698A (en) * 2006-10-23 2009-12-30 库克生物科技公司 Treated ECM material with enhanced compositional properties
US7674289B2 (en) 2005-07-29 2010-03-09 Grandhope Biotech Co., Ltd. Biological artificial ligament and method of making
CN101563450B (en) * 2006-09-21 2011-12-14 利真普膜股份有限公司 Method for preparing a cell-derived extracellular matrix membrane
US8197500B2 (en) 2005-08-04 2012-06-12 Grandhope Biotech Co., Ltd. Biological membrane-carrying aneurysm clip
US8292799B2 (en) 2005-07-29 2012-10-23 Grandhope Biotech Co., Ltd. Biological artificial blood vessel and method of making
CN102872479A (en) * 2012-10-31 2013-01-16 胡懿郃 Methods of derosination and deproteinization of xenogenic bone material and preparation method of substitute material for xenogenic bone material
CN106075580A (en) * 2016-06-08 2016-11-09 西安交通大学 A kind of method of external structure growth plate cartilage
CN106730003A (en) * 2016-12-11 2017-05-31 戴琪 A kind of preparation method for luring bone development type bone cement
CN108578773A (en) * 2018-03-12 2018-09-28 南京航空航天大学 Short route prepares the method for porous block xenogenesis bone renovating material and bone renovating material obtained by this method
CN108653819A (en) * 2018-03-12 2018-10-16 南京航空航天大学 Short route prepares the method for porous bone- xenograft bone meal repair materials and bone renovating material obtained by this method
CN111359016A (en) * 2020-03-13 2020-07-03 青岛海洋生物医药研究院 A kind of low antigenic fish skin tissue and its processing method
CN112023112A (en) * 2020-09-22 2020-12-04 天津中津生物发展有限公司 Bone hemostatic material with osteogenesis inducing activity and preparation method thereof
CN112807490A (en) * 2021-01-22 2021-05-18 西岭(镇江)医疗科技有限公司 Method for preparing oral collagen matrix material by using biological bone
CN114206403A (en) * 2019-06-07 2022-03-18 补骨生物技术公司 Method for manufacturing bone graft substitute having hole
CN114949350A (en) * 2022-05-31 2022-08-30 西岭(镇江)医疗科技有限公司 Collagen scaffold loaded with basic fibroblast growth factor
CN116172044A (en) * 2022-12-30 2023-05-30 杭州华迈医疗科技有限公司 A Physical Method for Removing Fat from Bovine Cancellous Bone
CN116459396A (en) * 2023-05-26 2023-07-21 山西医科大学第二医院(山西医科大学第二临床医学院) A method for reducing antigenic components of osteochondral grafts before transplantation
CN120714106A (en) * 2025-08-26 2025-09-30 吉林大学 A preparation method of a heterogeneous bone-microporous metal implant composite material

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358432C (en) * 2003-12-16 2008-01-02 威海市宇王水产有限公司 Production method of fish scale collagen
US7674289B2 (en) 2005-07-29 2010-03-09 Grandhope Biotech Co., Ltd. Biological artificial ligament and method of making
US8292799B2 (en) 2005-07-29 2012-10-23 Grandhope Biotech Co., Ltd. Biological artificial blood vessel and method of making
US7824447B2 (en) 2005-07-29 2010-11-02 Grandhope Biotech Co. Ltd. Biological artificial ligament and method of making
US8197500B2 (en) 2005-08-04 2012-06-12 Grandhope Biotech Co., Ltd. Biological membrane-carrying aneurysm clip
CN100485002C (en) * 2005-10-18 2009-05-06 中国人民解放军第三军医大学第一附属医院 Bone collagen gel liquid preparation method
JP2009519791A (en) * 2005-12-20 2009-05-21 サミット(ジーデー) バイオテク シーオー., エルテーデー. Living body wound dressing and production method
WO2007071164A1 (en) * 2005-12-20 2007-06-28 Summit(Gd) Biotech Co., Ltd Biological surgical patch and method of making
CN1986007B (en) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 Biological surgical patch
US8100970B2 (en) 2005-12-20 2012-01-24 Grandhope Biotech Co., Ltd. Biological surgical patch and method of making
WO2007071167A1 (en) * 2005-12-20 2007-06-28 Summit(Gd) Biotech Co., Ltd Biological artificial nerve guide and method of making
US8366770B2 (en) 2005-12-20 2013-02-05 Grandhope Biotech Co. Ltd. Biological artificial nerve guide and method of making
WO2007071168A1 (en) * 2005-12-20 2007-06-28 Summit (Gd) Biotech Co., Ltd Biological wound dressing and method of making
CN101563450B (en) * 2006-09-21 2011-12-14 利真普膜股份有限公司 Method for preparing a cell-derived extracellular matrix membrane
CN101616698A (en) * 2006-10-23 2009-12-30 库克生物科技公司 Treated ECM material with enhanced compositional properties
CN106390200A (en) * 2006-10-23 2017-02-15 库克生物科技公司 Processed ECM materials with enhanced component profiles
CN102872479A (en) * 2012-10-31 2013-01-16 胡懿郃 Methods of derosination and deproteinization of xenogenic bone material and preparation method of substitute material for xenogenic bone material
CN106075580A (en) * 2016-06-08 2016-11-09 西安交通大学 A kind of method of external structure growth plate cartilage
CN106075580B (en) * 2016-06-08 2019-05-03 西安交通大学 A method for constructing epiphyseal plate cartilage in vitro
CN106730003A (en) * 2016-12-11 2017-05-31 戴琪 A kind of preparation method for luring bone development type bone cement
CN108578773A (en) * 2018-03-12 2018-09-28 南京航空航天大学 Short route prepares the method for porous block xenogenesis bone renovating material and bone renovating material obtained by this method
CN108653819A (en) * 2018-03-12 2018-10-16 南京航空航天大学 Short route prepares the method for porous bone- xenograft bone meal repair materials and bone renovating material obtained by this method
CN108578773B (en) * 2018-03-12 2021-02-12 南京航空航天大学 Method for preparing porous block-shaped heterogeneous bone repair material in short process and bone repair material prepared by method
CN108653819B (en) * 2018-03-12 2021-02-12 南京航空航天大学 Method for preparing porous heterogeneous bone powder repairing material in short process and bone repairing material prepared by method
CN114206403A (en) * 2019-06-07 2022-03-18 补骨生物技术公司 Method for manufacturing bone graft substitute having hole
CN114206403B (en) * 2019-06-07 2023-01-31 补骨生物技术公司 Method for manufacturing bone graft substitute having hole
CN111359016A (en) * 2020-03-13 2020-07-03 青岛海洋生物医药研究院 A kind of low antigenic fish skin tissue and its processing method
CN112023112A (en) * 2020-09-22 2020-12-04 天津中津生物发展有限公司 Bone hemostatic material with osteogenesis inducing activity and preparation method thereof
CN112807490A (en) * 2021-01-22 2021-05-18 西岭(镇江)医疗科技有限公司 Method for preparing oral collagen matrix material by using biological bone
CN112807490B (en) * 2021-01-22 2022-04-15 西岭(镇江)医疗科技有限公司 Method for preparing oral collagen matrix material by using biological bone
CN114949350A (en) * 2022-05-31 2022-08-30 西岭(镇江)医疗科技有限公司 Collagen scaffold loaded with basic fibroblast growth factor
CN114949350B (en) * 2022-05-31 2024-04-02 西岭(镇江)医疗科技有限公司 Collagen scaffold loaded with basic fibroblast growth factor
CN116172044A (en) * 2022-12-30 2023-05-30 杭州华迈医疗科技有限公司 A Physical Method for Removing Fat from Bovine Cancellous Bone
CN116459396A (en) * 2023-05-26 2023-07-21 山西医科大学第二医院(山西医科大学第二临床医学院) A method for reducing antigenic components of osteochondral grafts before transplantation
CN120714106A (en) * 2025-08-26 2025-09-30 吉林大学 A preparation method of a heterogeneous bone-microporous metal implant composite material

Also Published As

Publication number Publication date
CN1214821C (en) 2005-08-17

Similar Documents

Publication Publication Date Title
CN1214821C (en) A New Method for Preparation of Heterogeneous Collagen Matrix
JP3643381B2 (en) Resorbable extracellular matrix for cartilage tissue reconstruction
AU2002309898B2 (en) EB matrix production from fetal tissues and its use for tissue repair
US5993844A (en) Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
RU2189257C1 (en) Biological material alloplant usable in reconstructive surgery
CN114949359B (en) Acellular matrix particle filler and preparation method thereof
RU2665962C1 (en) Bioresorable biological matrix for substitution of bone tissue defects and method of its obtaining
AU2002309898A1 (en) EB matrix production from fetal tissues and its use for tissue repair
CN1684589A (en) Vascularization enhanced graft constructs
CN101773687B (en) Preparation method of composite soft-tissue patch
Shaik et al. A review on the processing technique, physicochemical, and bioactive properties of marine collagen
CN102225218A (en) A method for preparing decellularized dermal matrix using ultrasound
CN104383601A (en) Skeletal muscle acellular matrix biological patch and preparation method thereof
CN108478869A (en) A kind of Regeneration and Repair bionical matrix of de- cell black carp skin and its preparation method and application
CN113694254A (en) Bone repair material, preparation method and application thereof
CN110193096A (en) A kind of marine origin biomimetic type cartilage material and preparation method thereof
EP2236544A1 (en) Collagen Implant
CN109550075A (en) A kind of preparation method of pigskin acellular dermal matrix dressing
CN105311676B (en) A kind of biologically active hard tissue engineering timbering material and preparation method thereof
CN116212114A (en) Preparation method of decalcified bone matrix
RU2342162C1 (en) Method for bone tissue biomaterial obtaining, and material for osteoplasty and tissue engineering obtained by such method
CN1552467A (en) Abnormal decelled bone based material and its preparation
CN113975464B (en) Periosteum-bone complex for reconstructing soft tissue-bone immune repair environment and preparation method
CN1216651C (en) Method for preparation of artificial bone antigen for biological origin
US20040265785A1 (en) Method for treating materials of biological origin, and collagen-elastin product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee